Inhibitors of clathrin-dependent endocytosis enhance TGFbeta signaling and responses

J Cell Sci. 2009 Jun 1;122(Pt 11):1863-71. doi: 10.1242/jcs.038729.

Abstract

Clathrin-dependent endocytosis is believed to be involved in TGFbeta-stimulated cellular responses, but the subcellular locus at which TGFbeta induces signaling remains unclear. Here, we demonstrate that inhibitors of clathrin-dependent endocytosis, which are known to arrest the progression of endocytosis at coated-pit stages, inhibit internalization of cell-surface-bound TGFbeta and promote colocalization and accumulation of TbetaR-I and SARA at the plasma membrane. These inhibitors enhance TGFbeta-induced signaling and cellular responses (Smad2 phosphorylation/nuclear localization and expression of PAI-1). Dynasore, a newly identified inhibitor of dynamin GTPase activity, is one of the most potent inhibitors among those tested and, furthermore, is a potent enhancer of TGFbeta. Dynasore ameliorates atherosclerosis in the aortic endothelium of hypercholesterolemic ApoE-null mice by counteracting the suppressed TGFbeta responsiveness caused by the hypercholesterolemia, presumably acting through its effect on TGFbeta endocytosis and signaling in vascular cells.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Animals
  • Apolipoproteins E / genetics
  • Apolipoproteins E / metabolism
  • Cadaverine / analogs & derivatives
  • Cadaverine / pharmacology
  • Carrier Proteins / genetics
  • Carrier Proteins / metabolism
  • Cell Line
  • Clathrin / metabolism*
  • Endocytosis / drug effects
  • Endocytosis / physiology*
  • Enzyme Inhibitors / pharmacology
  • Female
  • GTP-Binding Proteins
  • Hydrazones / pharmacology
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Monensin / pharmacology
  • Plasminogen Activator Inhibitor 1 / genetics
  • Plasminogen Activator Inhibitor 1 / metabolism
  • Protein Serine-Threonine Kinases / genetics
  • Protein Serine-Threonine Kinases / metabolism
  • Receptor, Transforming Growth Factor-beta Type I
  • Receptors, Transforming Growth Factor beta / genetics
  • Receptors, Transforming Growth Factor beta / metabolism
  • Signal Transduction / drug effects
  • Signal Transduction / physiology*
  • Smad2 Protein / metabolism
  • Transforming Growth Factor beta / metabolism*
  • Triflupromazine / pharmacology
  • beta-Cyclodextrins / pharmacology

Substances

  • Apolipoproteins E
  • Carrier Proteins
  • Clathrin
  • Enzyme Inhibitors
  • Hydrazones
  • N'-(3,4-dihydroxybenzylidene)-3-hydroxy-2-naphthahydrazide
  • Plasminogen Activator Inhibitor 1
  • Receptors, Transforming Growth Factor beta
  • SARA protein, mouse
  • Smad2 Protein
  • Smad2 protein, mouse
  • Transforming Growth Factor beta
  • beta-Cyclodextrins
  • Monensin
  • Protein Serine-Threonine Kinases
  • Receptor, Transforming Growth Factor-beta Type I
  • GTP-Binding Proteins
  • monodansylcadaverine
  • betadex
  • Cadaverine
  • Triflupromazine